American Journal of Cardiology
Volume 106, Issue 1 , Pages 51-55, 1 July 2010

Linguistic Analysis of In-Office Dialogue Among Cardiologists, Primary Care Physicians, and Patients With Mixed Dyslipidemia

  • Alan S. Brown, MD

      Affiliations

    • Midwest Heart Specialists, Naperville, Illinois
  • ,
  • Lynn Cofer-Chase, MSN, RN, CLS

      Affiliations

    • Midwest Heart Specialists, Naperville, Illinois
  • ,
  • Corey A. Eagan, MPH (Cand)

      Affiliations

    • MBS/Vox, Parsippany, New Jersey
    • Corresponding Author InformationCorresponding author: Tel: (973) 352-2067; fax: (973) 352-2567

Received 2 December 2009; received in revised form 7 February 2010; accepted 7 February 2010. published online 17 May 2010.

An in-office linguistic study was conducted to assess physician–patient discussions of mixed dyslipidemia. Naturally occurring interactions among 12 cardiologists, 12 primary care physicians, and 45 of their patients diagnosed with low levels of high-density lipoprotein cholesterol and being treated with prescription niacin extended-release were recorded. The participants were interviewed separately after the visit. The transcripts were analyzed using sociolinguistic techniques. Determined from the time at talk and the number of questions asked, the patients were moderately engaged in the visit conversations; however, most communication was physician-driven. Only 6% of the average visit was dedicated to disease education. Conversations about dyslipidemia were characterized by numerous laboratory values but rarely contained clear benchmarking or goal setting. In the postvisit interviews, the patients demonstrated a lack of understanding about their lipid levels and the next steps they should take. Both “HDL” [high-density lipoprotein] and “good cholesterol” were the most frequently mentioned aspects of dyslipidemia in these conversations; however, most physicians did not contextualize these components such that the patients were able to understand and retain the information after the visit. Although the conversations about treatment with niacin extended-release contained detailed information about how to manage the side effect of flushing, they lacked a clear description of this side effect. Also, missing from the dialogue was a balanced discussion of risks and benefits. Communication gaps were observed in the discussions regarding mixed dyslipidemia and its treatment with niacin extended-release. In conclusion, additional research is warranted to assess the efficacy of communication strategies to educate both physicians and patients about this condition and its treatment.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by funding from Abbott Laboratories, Abbott Park, Illinois.

PII: S0002-9149(10)00608-9

doi:10.1016/j.amjcard.2010.02.014

American Journal of Cardiology
Volume 106, Issue 1 , Pages 51-55, 1 July 2010